ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Aging"

  • Abstract Number: 0793 • ACR Convergence 2024

    Secular Changes in Widespread Pain Across Two Generations: The Framingham Heart Study

    David Felson1, Juan-Pablo Zertuche1, Nene Ukonu1, mike LaValley2, Margaret Clancy3 and Tuhina Neogi3, 1Boston University, Boston, MA, 2Boston University School of Public Health, Arlington, MA, 3Boston University Chobanian & Avedisian School of Medicine, Boston, MA

    Background/Purpose: In the general community, widespread musculoskeletal pain is common and often disabling..  Epidemiologic surveys in the US and Europe in the 1990s and early…
  • Abstract Number: 0903 • ACR Convergence 2024

    Distinct Impacts of Mosaic Loss of Chromosome Y and Genetic Risk on the Age of Onset in Patients with Rheumatoid Arthritis

    Shunsuke Uchiyama1, Yuki Ishikawa2, Katsunori Ikari3, Suguru Honda4, Yoichiro Kamatani5, Takahisa Gono6, Masataka Kuwana7 and Chikashi Terao8, 1Nippon Medical school/ RIKEN, Tokyo, Japan, 2RIKEN, Yokohama, Japan, 3Tokyo Women's Medical University, Shinjuku, Japan, 4Tokyo Women's Medical University, Tokyo, Japan, 5Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan, 6Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 7Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan, Tokyo, Japan, 8RIKEN, Tokyo, Japan

    Background/Purpose: The age of onset of rheumatoid arthritis (RA) is becoming older worldwide. Since patients with late-onset RA (LORA) have unique clinical characteristics, including acute…
  • Abstract Number: 0924 • ACR Convergence 2024

    The Cytosolic DNA Sensor AIM2 Regulates Bone Homeostasis Through Bone Progenitor Cell Differentiation

    Jia (Sijia) Chen1, Yukiko Maeda2, Catherine Manning3, Victor Le4, Jae-Hyuck Shim5, Katherine A. Fitzgerald6 and Ellen Gravallese7, 1Brigham and Women's Hospital, Boston, MA, 2Sanofi, worcester, MA, 3Brigham and Women's Hospital, Dedham, MA, 4Digital Biology, Boston, MA, 5University of Massachusetts, Worcester, MA, 6UMass Chan Medical School, Worchester, MA, 7Brigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA

    Background/Purpose: Innate sensing pathways and inflammasomes play an important role in autoimmunity and aging. AIM2 is a DNA sensor that triggers inflammasome assembly in myeloid…
  • Abstract Number: 0982 • ACR Convergence 2024

    Urinary Incontinence Among Individuals with Systemic Lupus Erythematosus

    Gabriel Salazar1, Jinoos Yazdany2, Courtney Hoge3, S. Sam Lim3, Scott Bauer2 and Laura Plantinga4, 1University of California, San Francisco, SF, CA, 2UCSF, San Francisco, CA, 3Emory University, Atlanta, GA, 4University of California, San Francisco, San Francisco, CA

    Background/Purpose: Although urinary symptoms are often reported by people with SLE and may substantially affect quality of life, little is known about the burden of…
  • Abstract Number: 0987 • ACR Convergence 2024

    Correlates of Depression in Individuals with Chronic Fatigue Syndrome

    Joan Morny1, Raheem Robertson1, Terrylyna Baffoe-Bonnie2, Ufuoma Mamoh3, Soziema Salia4 and Ehizogie Edigin5, 1Piedmont Athens Regional Medical Center, athens, GA, 2Medstar Health Union Memorial Hospital, Baltimore, MD, 3Medstar Union Memorial Hospital, Baltimore, MD, 4MedStar Union Memorial Hospital, Towson, MD, 5The University of Texas Health Science Center, houston, TX

    Background/Purpose: Chronic fatigue syndrome (CFS) is a multifaceted illness with a wide range of symptoms. It shares similar symptomatology with depression. In situations where patients have both…
  • Abstract Number: 1064 • ACR Convergence 2024

    Inpatient and Outpatient Palliative Care Referral Practices for Patients with Rheumatic Disease: Retrospective Chart Review at a Single Academic Medical Center

    Shannon Herndon1, Jack Kimball1 and David Leverenz2, 1Duke University Medical Center, Durham, NC, 2Duke University, Durham, NC

    Background/Purpose: Palliative medicine prioritizes quality of life and relief of suffering in serious illness. Despite high morbidity and mortality in rheumatic disease, data suggests that…
  • Abstract Number: 1191 • ACR Convergence 2024

    Discordant Associations Among Chronological and Biological Age with Multi-joint Osteoarthritis and Symptom Burden: The Johnston County Health Study

    Liubov Arbeeva1, Yvonne Golightly2, Cameron Kurz3, Matlock Jeffries4, Virginia Kraus5, Richard Loeser6, Duncan Lascelles7 and Amanda Nelson3, 1University of North Carolina, Chapel Hill, Carrboro, NC, 2University of Nebraska Medical Center, Omaha, NE, 3University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Duke University, Durham, NC, 6University of North Carolina, Chapel Hill, NC, 7North Carolina State University, Raleigh, NC

    Background/Purpose: Biological age (BA) may be superior to chronological age (CA) in predicting mortality and age-related conditions such as diabetes and cognitive/functional decline (PMID35715611), as…
  • Abstract Number: 1327 • ACR Convergence 2024

    Association of Rheumatoid Arthritis and Frailty Status with Mortality in Patients with Renal Cell Carcinoma

    Sherwin Novin1, Sarah Holt2, Maya Swaminathan3, Jonathan Wright2, John Gore2, Kimme Hyrich4, Sizheng Zhao5, Jeffrey Sparks6, Una Makris7, Maria Suarez-Almazor8, Petros Grivas2, Sarah Psutka2 and Namrata Singh9, 1University of Washington, Seattle, WA, 2University of Washington, Seattle, 3MultiCare, Newcastle, WA, 4Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom, 5Centre for Musculoskeletal Research, The University of Manchester, Liverpool, United Kingdom, 6Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, 7UT Southwestern Medical Center and Dallas VA, Dallas, TX, 8MD Anderson Cancer Center, Houston, TX, 9University of Washington, Bellevue, WA

    Background/Purpose: Few studies have evaluated clinical outcomes and prognosis of patients with cancer with and without rheumatoid arthritis (RA). Renal cell carcinoma (RCC) is particularly…
  • Abstract Number: 1371 • ACR Convergence 2024

    DMARD Utilization Pattern in Older Adults with Rheumatoid Arthritis

    Daniela Seelmann1, Jiha Lee2 and Devyani Misra3, 1Beth Israel Deaconess Medical Canter, Newton, MA, 2University of Michigan, Ann Arbor, MI, 3Beth Israel Deaconess Medical Center, Boston, Boston, MA

    Background/Purpose: Disease modifying anti-rheumatic drug (DMARD) use in older adults with rheumatoid arthritis (RA) is challenging due to unique geriatric issues, such as multimorbidity, polypharmacy,…
  • Abstract Number: 1636 • ACR Convergence 2024

    Age-associated B Cells Contribute to Inflammation of Takayasu’s Arteritis in an Antibody-secreting Cell Differentiation Independent Manner

    Chenglong Fang1, Xiaochuan Sun2, Shangyi Jin2, Lihong du2, Jing Li2, Xiaofeng Zeng3, Yuexin Chen4, Mengtao Li5 and Xinping Tian3, 1Department of Rheumatology, Second Affiliated Hospital of Fujian Medical University, Quanzhou, China (People's Republic), 2Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China, 3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 4Department of Vascular Surgery, Peking Union Medical College Hospital, Beijing, China, 5Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China

    Background/Purpose: Although Takayasu’s arteritis (TAK) is not a prototypical autoantibody-mediated autoimmune disease, several lines of evidence suggested the pathogenic potential of B cells. However, limited…
  • Abstract Number: 0028 • ACR Convergence 2024

    Human Meniscus Histopathological and Transcriptomic Changes at Early and Advanced Stages of Knee Osteoarthritis

    Takuya Sakamoto1, Hannah Swahn1, Merissa Olmer1, Rachel Miller2, Anne-Marie Malfait3 and Martin Lotz1, 1Scripps Research Institute, La Jolla, CA, 2Rush University Medical Center, Chicago, IL, 3Rush University Medical Center, Division of Rheumatology, Chicago, IL

    Background/Purpose: The knee menisci are essential elements in joint biomechanics and meniscus damage is a driver of cartilage destruction and knee osteoarthritis. Meniscus damage and…
  • Abstract Number: 1887 • ACR Convergence 2024

    High Rates of Cost-Related Medication Non-Adherence Among Younger Patients Receiving Immunosuppression Are Exacerbated by Other Chronic Conditions

    Samuel Good1, Bryant England2 and Elizabeth Volkmann3, 1University of California, Los Angeles, Los Angeles, CA, 2University of Nebraska Medical Center, Omaha, NE, 3University of California, Department of Medicine, Los Angeles, CA, USA, Los Angeles

    Background/Purpose: Medication non-adherence is associated with worse autoimmune disease outcomes; however, it is unknown whether adherence rates related to cost barriers differ across diseases and…
  • Abstract Number: 0145 • ACR Convergence 2024

    Community Mobility in a Diverse Cohort of Individuals with Systemic Lupus Erythematosus

    Leila Milanfar1, Jinoos Yazdany2, Amanda Eudy3, Courtney Hoge4, Charmayne M. Dunlop-Thomas5, Patti Katz6 and Laura Plantinga7, 1University of California San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Duke University, Raleigh, NC, 4Emory University, Atlanta, GA, 5Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 6UCSF, San Rafael, CA, 7University of California, San Francisco, San Francisco, CA

    Background/Purpose: Measurement of the extent to which individuals move throughout their community and participate in social activities (“community mobility”) can provide a snapshot of how…
  • Abstract Number: 2090 • ACR Convergence 2024

    Prevalence of Steatotic Liver Disease and Liver Fibrosis Among Patients with Osteoarthritis (OA)

    Athanasios Vassilopoulos1, Stephanos Vassilopoulos2, Markos Kalligeros2, Eleftherios Mylonakis3 and Anthony M. Reginato4, 1Warren Alpert Medical School of Brown University, Providence, RI, 2Division of Internal Medicine, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island, Providence, RI, 3Department of Medicine, Houston Methodist Hospital, Houston, 4Brown University, Providence, RI

    Background/Purpose: Steatotic liver disease (SLD) and osteoarthritis (OA) affect a large proportion of the general population and prevalence of both is expected to increase given…
  • Abstract Number: 0166 • ACR Convergence 2024

    Limitations in Activities of Daily Living Among Individuals with SLE

    Laura Plantinga1, Jinoos Yazdany2, Courtney Hoge3, Charmayne M. Dunlop-Thomas4 and Patti Katz5, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Emory University, Atlanta, GA, 4Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 5UCSF, San Rafael, CA

    Background/Purpose: A better understanding of the capacity of individuals with SLE to perform routine daily life tasks is needed to effectively support the independence and…
  • 1
  • 2
  • 3
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology